Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
01 Agosto 2024 - 5:17PM
Business Wire
Cencora, Inc. (NYSE: COR) today announced that it has agreed to
repurchase shares of its common stock from Walgreens Boots Alliance
Holdings LLC in the amount of approximately $250 million in
concurrence with Walgreens Boots Alliance’s sale of Cencora shares
pursuant to Rule 144 under the Securities Act of 1933, as
amended.
Cencora intends to repurchase shares from Walgreens Boots
Alliance at the price per share equal to the price in the Rule 144
sale. The concurrent share repurchase will be made under Cencora’s
share repurchase program and the repurchased shares will be held in
treasury.
About Cencora Cencora is a
leading global pharmaceutical solutions organization centered on
improving the lives of people and animals around the world. We
partner with pharmaceutical innovators across the value chain to
facilitate and optimize market access to therapies. Care providers
depend on us for the secure, reliable delivery of pharmaceuticals,
healthcare products, and solutions. Our 46,000+ worldwide team
members contribute to positive health outcomes through the power of
our purpose: We are united in our responsibility to create
healthier futures. Cencora is ranked #10 on the Fortune 500 and #24
on the Global Fortune 500 with more than $250 billion in annual
revenue.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240801321448/en/
Bennett S. Murphy Senior Vice President, Head of
Investor Relations & Treasury 610-727-3693
Bennett.Murphy@cencora.com
Cencora (NYSE:COR)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024
Cencora (NYSE:COR)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024